137 related articles for article (PubMed ID: 17654677)
1. Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia.
Kasner MT; Laury A; Kasner SE; Carroll M; Luger SM
Am J Hematol; 2007 Dec; 82(12):1110-2. PubMed ID: 17654677
[TBL] [Abstract][Full Text] [Related]
2. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
3. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
4. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
5. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
Schmitt A; Reinhardt P; Hus I; Tabarkiewicz J; Roliñski J; Barth T; Giannopoulos K; Dmoszyñska A; Wiesneth M; Schmitt M
Transfusion; 2007 Sep; 47(9):1588-94. PubMed ID: 17725721
[TBL] [Abstract][Full Text] [Related]
6. [Occlusion of the femoral arteries in de novo AML].
Ressel A; Trümper L; Bäsecke J
Med Klin (Munich); 2007 May; 102(5):388-92. PubMed ID: 17497090
[TBL] [Abstract][Full Text] [Related]
7. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
8. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
9. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
10. Transcranial Doppler ultrasonography in intensive care.
Rasulo FA; De Peri E; Lavinio A
Eur J Anaesthesiol Suppl; 2008; 42():167-73. PubMed ID: 18289437
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
[TBL] [Abstract][Full Text] [Related]
12. [Intracerebral steal after acetazolamide administration].
Vastagh I; Pozsár M; Folyovich A; Debreczeni R; Pálvölgyi L; Bereczki D; Szirmai I
Ideggyogy Sz; 2008 May; 61(5-6):168-73. PubMed ID: 18567392
[TBL] [Abstract][Full Text] [Related]
13. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
[TBL] [Abstract][Full Text] [Related]
16. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
[TBL] [Abstract][Full Text] [Related]
17. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
19. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
[TBL] [Abstract][Full Text] [Related]
20. Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia.
Galera P; Haynes S; Sulmasy P; Bailey JA; Greene M; Vauthrin M; Brettler D; Liebmann J; Mark Madison J; Weinstein R
J Clin Apher; 2016 Aug; 31(4):393-7. PubMed ID: 26053950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
